BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference
BioMarin Pharmaceutical (NASDAQ: BMRN) will present at the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021, at 3:30 PM ET. An audio webcast of the presentation will be available live, with an archived version accessible on the company's website for a limited time afterwards. BioMarin focuses on developing therapies for rare disorders and has a diverse portfolio of six commercialized products alongside several clinical candidates. For more details, visit www.biomarin.com.
- None.
- None.
Insights
Analyzing...
SAN RAFAEL, Calif., June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2021-napa-biopharma-conference-301312288.html
SOURCE BioMarin Pharmaceutical Inc.